Scientific Sessions 2025  /  New Onset HFpEF and “LVH”—Don't Miss the Treatable Zebra: How to Diagnose and Treat Cardiac Amyloidosis in 2025  /  Red Flags in New Onset HFpEF that Should Raise Suspicion for Cardiac Amyloidosis
Logo

American Heart Association

  62
  0

Final ID:

Red Flags in New Onset HFpEF that Should Raise Suspicion for Cardiac Amyloidosis

  • Alexander, Kevin  ( Stanford University , Palo Alto , California , United States )
  • Nativi-nicolau, Jose  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Raymer, David  ( University of Colorado , Aurora , Colorado , United States )
    • Author Disclosures:
    Kevin Alexander: DO have relevant financial relationships ; Consultant:Arbor Biotechnologies:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:Alexion:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Bridgebio:Active (exists now) ; Consultant:Alnylam:Active (exists now) | Jose Nativi-Nicolau: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alnylam:Active (exists now) ; Research Funding (PI or named investigator):Natera:Active (exists now) ; Research Funding (PI or named investigator):Alexion:Active (exists now) | David Raymer: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

New Onset HFpEF and “LVH”—Don't Miss the Treatable Zebra: How to Diagnose and Treat Cardiac Amyloidosis in 2025

Saturday, 11/08/2025 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
Solid Organ Transplant for Cardiac Amyloidosis: Historical Relic or Modern Necessity?

Ambardekar Amrut, Panjrath Gurusher

AL Cardiac Amyloidosis: A High Risk, High Reward Condition with Contemporary Treatment

Maurer Mathew, Witteles Ronald

More abstracts from these authors:
Discussant: ATTR-Specific Medication in Dual Pathology Aortic Stenosis and Transthyretin Cardiac Amyloidosis

Nativi-nicolau Jose

A Diamond in the Rough: Clinical Pearls from the ICU
To discuss general management strategies for multi-organ failure in the patient with severe refractory cardiogenic shock. Discuss prognostication of extra-cardiac organ dysfunction in patients resuscitated from cardiogenic shock.

Sabe Marwa, Raymer David, Cho Sung-min

You have to be authorized to contact abstract author. Please, Login
Not Available